A randomised, double-blind, placebo-controlled trial of<i>Bifidobacterium bifidum</i>CCFM16 for manipulation of the gut microbiota and relief from chronic constipation-Reference-Cited by-同舟云学术

A randomised, double-blind, placebo-controlled trial ofBifidobacterium bifidumCCFM16 for manipulation of the gut microbiota and relief from chronic constipation

Published:2022 Issue:3 Volume:13 Page:1628-1640
ISSN:2042-6496
Container-title:Food & Function
language:en
Short-container-title:Food Funct.

Author:

Wang Luyao¹²^ORCID,Wang Linlin¹²,Tian Peijun¹²,Wang Botao¹²,Cui Shumao¹²,Zhao Jianxin¹²³⁴^ORCID,Zhang Hao¹²³⁴⁵^ORCID,Qian Long⁶,Wang Qun⁶,Chen Wei¹²³^ORCID,Wang Gang¹²³⁴^ORCID

Affiliation:

1. State Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi 214122, P. R. China

2. School of Food Science and Technology, Jiangnan University, Wuxi 214122, P. R. China

3. National Engineering Center of Functional Food, Jiangnan University, Wuxi 214122, P. R. China

4. (Yangzhou) Institute of Food Biotechnology, Jiangnan University, Yangzhou 225004, P. R. China

5. Wuxi Translational Medicine Research Center and Jiangsu Translational Medicine Research Institute Wuxi Branch, Wuxi 214122, P. R. China

6. The Tinghu People's Hospital, Yancheng 224002, P. R. China

Abstract

CCFM16 raises Firmicutes and Clostridia then SCFAs levels to relieve constipation. Several taxa in Clostridiales prevent CCFM16 from properly functioning.

Funder

National Key Research and Development Program of China

Fundamental Research Funds for the Central Universities

National Natural Science Foundation of China

Publisher

Royal Society of Chemistry (RSC)

Subject

General Medicine,Food Science

Link

http://pubs.rsc.org/en/content/articlepdf/2022/FO/D1FO03896F

Reference44 articles.

1. Bowel Disorders